Highly accomplished biosciences industry veteran will lead financial strategy for ground-breaking technology company

Micropep Technologies (Micropep), the global leader in micropeptide technology for agricultural applications, today announced the appointment of Jeff Bell as its Chief Financial Officer. Bell brings a wealth of experience in bioscience finance and operations to Micropep. His appointment marks a significant step in Micropep’s journey towards revolutionizing sustainable agriculture. He will lead Micropep’s financial planning, analysis, and reporting and will play a vital role in the company’s strategic direction.

Bell, a qualified chartered accountant, started his career in Australia in 1990. Over the past 30 years, he’s held several leadership roles, directing organizations to achieve optimum profitability and effective utilization of business assets and human resources. His experience includes founding Sterilis, where he invented a groundbreaking on-site sterilization system that significantly reduced costs and risk, raising $14 million in equity investments and securing major clients such as Fresenius Medical Care. His successful career also includes serving as COO/CFO at Norwood Abbey Ltd and establishing a strong financial track record at Norwood Immunology Ltd and Draffin Walker & Co.

As CFO of Micropep, Bell will work side-by-side with CEO Thomas Laurent and lead the company’s financial strategy. Micropep is focused on delivering breakthrough, cost-effective solutions to agricultural markets. Bell’s responsibilities will include all aspects of Micropep’s delivery of positive financial outcomes to farmers, the agricultural supply chain, and the company’s shareholders.

Micropep’s products address the exponentially growing demand for global food security. To meet the needs of a projected world population of 10 billion by 2050, food production must increase by 70%. Micropep’s products will be instrumental in helping meet the worldwide need for sustainable and regenerative agriculture by overcoming diseases and weeds that result in crop losses of more than $90 billion annually.

“Since our founding, the Micropep science team has proven our technologies' efficacy in the field. As we progress to proving and delivering value to customers and shareholders, Jeff’s experience and leadership will be critical,” said Thomas Laurent, CEO of Micropep. “Micropep’s vision is to use innovative micropeptide technology to secure the future of tomorrow’s food. Farmers need affordable and sustainable solutions to protect their crops. We believe our micropeptides-based products are the answer to developing the next generation of sustainable crop protection tools that farmers need today and in the future. Jeff’s industry experience and passion for the sector will be a critical building block as our organization embarks on the next growth phase to provide safer and more efficient alternatives to conventional crop protection."

“I could not be more excited to join the team at Micropep,” said Bell. “This company stands at the forefront of the agricultural revolution with its pioneering micropeptide technology. With over three decades of experience in bioscience finance and operations, I am eager to contribute to the strategic growth and financial strength of Micropep.”

About Micropep Technologies

Micropep Technologies, with operations in the US and France, is a global leader in breakthrough micropeptide technology. The company has developed a proprietary AI-powered discovery platform for micropeptides, which are short protein molecules naturally produced by plant cells and have an infinite number of applications. Micropep is building the next generation of natural solutions addressing global challenges in multiple markets, with a key focus in agriculture. For more information, please visit https://www.micro-pep.com/

View source version on businesswire.com: https://www.businesswire.com/news/home/20231121928604/en/